Toru Tanaka

Toru Tanaka

Auto-generated profile, based on publicly available information

Toru Tanaka

Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, 565-0871, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TTToru Tanaka
Toru Tanaka
KIKohei Izawa
Kohei Izawa
YMYusuke Maniwa
Yusuke Maniwa
MOMaki Okamura
Maki Okamura
AOAtsumasa Okada
Atsumasa Okada
YOYoshiaki Okada
Yoshiaki Okada
Although transcription factors regulating endothelial cell (EC)-specific gene expression have been identified, it is not known how those factors induce EC-specificity. We previously reported that DNA hypomethylation of the proximal promoter elicits EC-specific expression of Roundabout4 (Robo4). However, the mechanisms establishing EC-specific hypomethylation of the Robo4 promoter remain unknown. In this study, we demonstrated that the hypermethylated Robo4 proximal promoter is demethylated as human iPS cells differentiate into endothelial cells. Reporter assays demonstrated that ETV2, an ETS family transcription factor, bound to ETS motifs in the proximal promoter and activated Robo4 expression. Immunoprecipitation demonstrated direct interaction between ETV2 and methylcytosine-converting enzymes TET1 and TET2. Adenoviral expression of ETV2-TET1/TET2 complexes demethylated the Robo4 promoter and induced Robo4 expression in non-ECs. In summary, we propose a novel regulatory model of EC-specific gene expression via promoter demethylation induced by ETV2-TET1/TET2 complexes during endothelial differentiation.